Reyataz, an AIDS drug also known as atazanavir, is facing a U.S. Food and Drug Administration advisory committee today.

FORBES: Unleashing Pharma's Dogs

The first such medicine, Pargluva, received a thumbs up last week from a U.S. Food and Drug Administration advisory committee, despite serious side effects that include an increased risk of congestive heart failure.

FORBES: Magazine Article

An advisory committee to the federal Food and Drug Administration recommended last year that the FDA bar people with chronic fatigue syndrome from donating.

WSJ: Chronic-Fatigue Paper Called Into Question